Non-invasive Brain Target institutions: hospitals, ERs, and field responders that require rapid brain bleed detection. Leverage the non-invasive, rapid triage capability to position as a life-saving diagnostic tool for stroke, hemorrhage, and traumatic brain injury workflows.

Strategic Partnerships Engage academic medical centers and Level 1 trauma centers (notably University of Cincinnati collaboration) to expand clinical validation, pilot programs, and co-development opportunities that can drive early-adopter deployments.

Leadership & Growth Recent executive appointments (CEO Gary Kurdziel and CCO Eric Bailey) indicate a formal go-to-market strategy. Align outreach around commercialization milestones, product launches, and insurance reimbursement discussions to accelerate revenue cycles.

Funding Signals Recognize early-stage investor backing from St. Elizabeth Healthcare and modest funding rounds; leverage this to pursue strategic investors, regional hospital networks, and grant/funding programs for expansion and broader field trials.

Market Positioning Position against competitors in neurodiagnostics by highlighting speed, non-invasiveness, and applicability across pre-hospital and hospital settings. Target mid-sized hospital networks and regional health systems seeking rapid triage tools to improve patient outcomes and throughput.